NF-κB-dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity.
Ghislat G, Cheema AS, Baudoin E, Verthuy C, Ballester PJ, Crozat K, Attaf N, Dong C, Milpied P, Malissen B, Auphan-Anezin N, Manh TPV, Dalod M, Lawrence T.
Ghislat G, et al. Among authors: ballester pj.
Sci Immunol. 2021 Jul 9;6(61):eabg3570. doi: 10.1126/sciimmunol.abg3570.
Sci Immunol. 2021.
PMID: 34244313
Free article.